These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25737976)

  • 1. Plasma Fibrinogen in Type 2 Diabetic Patients with Metabolic Syndrome and its Relation with Ischemic Heart Disease (IHD) and Retinopathy.
    Mahendra JV; Kumar SD; Anuradha TS; Talikoti P; Nagaraj RS; Vishali V
    J Clin Diagn Res; 2015 Jan; 9(1):BC18-21. PubMed ID: 25737976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factor analyses for macrovascular complication in nonobese NIDDM patients. Multiclinical Study for Diabetic Macroangiopathy (MSDM).
    Ito H; Harano Y; Suzuki M; Hattori Y; Takeuchi M; Inada H; Inoue J; Kawamori R; Murase T; Ouchi Y; Umeda F; Nawata H; Orimo H
    Diabetes; 1996 Jul; 45 Suppl 3():S19-23. PubMed ID: 8674883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Syndrome in Type 2 Diabetes Mellitus Patients: Prevalence, Risk Factors, and Associated Microvascular Complications.
    Asghar S; Asghar S; Shahid S; Fatima M; Bukhari SMH; Nadeem Siddiqui S
    Cureus; 2023 May; 15(5):e39076. PubMed ID: 37323312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen Levels in Type 2 Diabetes Mellitus and it's Correlation with Microvascular Microvascular Complications.
    M RK; L H
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of developing diabetes mellitus and vascular complications in patients with impaired fasting glucose.
    Sharifi F; Jaberi Y; Mirzamohammadi F; Mirzamohammadi H; Mousavinasab N
    Indian J Endocrinol Metab; 2013 Sep; 17(5):899-905. PubMed ID: 24083174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report of the committee on the classification and diagnostic criteria of diabetes mellitus.
    ; Seino Y; Nanjo K; Tajima N; Kadowaki T; Kashiwagi A; Araki E; Ito C; Inagaki N; Iwamoto Y; Kasuga M; Hanafusa T; Haneda M; Ueki K
    J Diabetes Investig; 2010 Oct; 1(5):212-28. PubMed ID: 24843435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy.
    Asakawa H; Tokunaga K; Kawakami F
    J Diabetes Complications; 2000; 14(3):121-6. PubMed ID: 10989319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contributions of fasting and postprandial blood glucose increments to oxidative stress and inflammation in dyslipidemic type 2 diabetic patients with stable ischemic heart disease.
    Djindjic B; Kostic T; Radovanovic Z; Djindjic N; Lazovic M; Zivic M; Perisic Z; Krstic N
    Int J Cardiol; 2017 Jan; 227():611-616. PubMed ID: 27816305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of plasma fibrinogen level and blood pressure with diabetic retinopathy, and renal complications associated with proliferative diabetic retinopathy, in Type 2 diabetes mellitus.
    Fujisawa T; Ikegami H; Yamato E; Kawaguchi Y; Ueda H; Shintani M; Nojima K; Kawabata Y; Ono M; Nishino T; Noso S; Yamada K; Babaya N; Okamoto N; Ohguro N; Fukuda M; Ogihara T
    Diabet Med; 1999 Jun; 16(6):522-6. PubMed ID: 10391402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum high sensitivity C-reactive protein, nitric oxide metabolites, plasma fibrinogen, and lipid parameters in Indian type 2 diabetic males.
    Sarangi R; Padhi S; Mohapatra S; Swain S; Padhy RK; Mandal MK; Patro SK; Kumar S
    Diabetes Metab Syndr; 2012; 6(1):9-14. PubMed ID: 23014248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperfibrinogenemia and metabolic syndrome in type 2 diabetes: a population-based study.
    Bruno G; Cavallo-Perin P; Bargero G; Borra M; D'Errico N; Macchia G; Pagano G
    Diabetes Metab Res Rev; 2001; 17(2):124-30. PubMed ID: 11307177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central blood pressure and pulse wave velocity: relationship to target organ damage and cardiovascular morbidity-mortality in diabetic patients or metabolic syndrome. An observational prospective study. LOD-DIABETES study protocol.
    Gómez-Marcos MA; Recio-Rodríguez JI; Rodríguez-Sánchez E; Castaño-Sánchez Y; de Cabo-Laso A; Sánchez-Salgado B; Rodríguez-Martín C; Castaño-Sánchez C; Gómez-Sánchez L; García-Ortiz L
    BMC Public Health; 2010 Mar; 10():143. PubMed ID: 20298558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of metabolic syndrome's components on the development of cardiovascular disease in a Jordanian cohort with metabolic syndrome.
    Haddad FH; Mahafza SM
    Saudi Med J; 2008 Sep; 29(9):1299-305. PubMed ID: 18813416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term treatment with metformin improves the cardiovascular risk profile in first-degree relatives of subjects with type 2 diabetes mellitus who have a metabolic syndrome and normal glucose tolerance without changes in C-reactive protein or fibrinogen.
    Lima LM; Wiernsperger N; Kraemer-Aguiar LG; Bouskela E
    Clinics (Sao Paulo); 2009 May; 64(5):415-20. PubMed ID: 19488607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.
    Abdul-Ghani M; Nawaf G; Nawaf F; Itzhak B; Minuchin O; Vardi P
    Isr Med Assoc J; 2006 Jun; 8(6):378-82. PubMed ID: 16833164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors for diabetic maculopathy, and its relationship to diabetic retinopathy in elderly Japanese patients with type 2 diabetes mellitus.
    Yamamoto T; Iimuro S; Ohashi Y; Sone H; Yamashita H; Ito H;
    Geriatr Gerontol Int; 2012 Apr; 12 Suppl 1():134-40. PubMed ID: 22435949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and ischemic heart disease in gout.
    Vázquez-Mellado J; García CG; Vázquez SG; Medrano G; Ornelas M; Alcocer L; Marquez A; Burgos-Vargas R
    J Clin Rheumatol; 2004 Jun; 10(3):105-9. PubMed ID: 17043480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of diabetic retinopathy in screening-detected diabetes mellitus: results from the Gutenberg Health Study (GHS).
    Ponto KA; Koenig J; Peto T; Lamparter J; Raum P; Wild PS; Lackner KJ; Pfeiffer N; Mirshahi A
    Diabetologia; 2016 Sep; 59(9):1913-9. PubMed ID: 27314413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic complications and risk factors in patients with type 1 diabetes mellitus--retrospective analysis].
    Kozek E; Górska A; Fross K; Marcinowska A; Citkowska A; Sieradzki J
    Przegl Lek; 2003; 60(12):773-7. PubMed ID: 15058014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.